NCT03581773View on ClinicalTrials.gov

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

December 20, 2026

Study Completion Date

December 20, 2028

Conditions
MucositisStomatitis
Interventions
DRUG

Folic Acid

5 mg pr day for 12 weeks

DRUG

Placebo Oral Tablet

1 placebo pill pr day for 12 weeks

Trial Locations (2)

2730

RECRUITING

Department of Oncology, Herlev Hospital, Herlev

8000

RECRUITING

Aarhus University Hospital, Department of oncology, Aarhus

All Listed Sponsors
lead

Niels Fristrup

OTHER